AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference ...

Abcuro, Inc., a late-stage clinical biotechnology company developing potentially first-in-class immunotherapies designed to ...

Preclinical data findings illustrate power of Cellarity’s discovery platform, which leverages transcriptomics and AI to discover previously unseen biological pathways to create novel cell ...

Planned acquisition of brelovitug for chronic hepatitis delta virus (HDV) with Breakthrough Therapy and PRIME ...

Jaguar CEO Lisa Conte presenting December 10 from 3:25pm - 3:35pm Eastern at the Emerging Growth Conference to provide updates on near-term catalysts; Click here to registerInitial results of ongoing ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...

New "Financial First Aid for Nurses" Campaign Helps Nurses Treat Their Money Like They Treat Their Patients LAKE WORTH, ...

Presentation included previously disclosed primary results from the pivotal ARES Phase 3 single-arm trial evaluating MaaT013 (Xervyteg®) in treating refractory severe acute Graft-versus-Host Disease ...

These results represent the first scientific milestone expected by regulatory agencies and potential pharmaceutical partnersNew patent application currently in preparationResults obtained in line with ...

UNCAGED Innovations, the world’s first biomaterial company to create a sustainable leather alternative from grains, today announced a partnership with Academy Award–winning actor and producer Natalie ...

HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the ...

Technion’s highest honor recognizes Mirkin for pioneering discoveries in nanoscience, including the Spherical Nucleic Acid (SNA) technology that forms the foundation of Flashpoint’s structural ...